← Back to Search

Behavioral Intervention

Patients with OUD, eligible for treatment with buprenorphine for Opioid Use Disorder

N/A

Recruiting

Research Sponsored by University of Pennsylvania

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up substance use in past 7 days, measured at 14, 30, 90 days

Awards & highlights

Study Summary

This trial aims to create and test a new way of delivering treatment for Opioid Use Disorder (OUD) using telehealth. They want to find out what works best in this type of treatment

Who is the study for?

This trial is for individuals with opioid use disorder (OUD). It includes those currently in a 1-3 month buprenorphine treatment program and those approved for such treatment but not yet started. Participants must be willing to receive care via telehealth.Check my eligibility

What is being tested?

The study is testing a tailored telehealth intervention designed to improve OUD treatment delivery, specifically using the medication buprenorphine. The trial will develop this intervention with stakeholder input and measure its effectiveness through clinical outcomes and patient satisfaction.See study design

What are the potential side effects?

Since the focus of this trial is on the delivery method of OUD treatment rather than a new medication, side effects are primarily related to buprenorphine use which can include nausea, drowsiness, constipation, sweating, or potential dependency.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ substance use in past 7 days, measured at 14, 30, 90 days

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~substance use in past 7 days, measured at 14, 30, 90 days

This trial's timeline: 3 weeks for screening, Varies for treatment, and substance use in past 7 days, measured at 14, 30, 90 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Treatment Engagement

Secondary outcome measures

Acceptability

Days of medication for OUD

Feasibility of intervention

+3 more

Trial Design

1Treatment groups

Experimental Treatment

Group I: Patients with OUD, eligible for treatment with buprenorphineExperimental Treatment1 Intervention

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of PennsylvaniaLead Sponsor

2,009 Previous Clinical Trials

42,894,593 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are individuals currently able to enroll in this ongoing medical study?

"According to the information available on clinicaltrials.gov, this current clinical trial is indeed actively seeking eligible participants. The trial was initially listed on 12/8/2023 and underwent its most recent update on 3/25/2024."

Answered by AI

How many individuals are participating in the entirety of this medical study?

"Indeed, as per the details on clinicaltrials.gov, this specific medical trial is actively seeking suitable participants. The trial was publicly announced on December 8th, 2023, and its most recent update was made on March 25th, 2024. A total of 60 eligible candidates are being sought from a single designated site."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Improving Access to Opioid Use Disorder Treatment Among Marginalized Patients With a Tailored Telehealth Intervention

2023. "Improving Access to Opioid Use Disorder Treatment Among Marginalized Patients With a Tailored Telehealth Intervention". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06341608.

All > Paid Studies Baltimore > Philadelphia